These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38321916)

  • 1. Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial.
    Poirot MG; Ruhe HG; Mutsaerts HMM; Maximov II; Groote IR; Bjørnerud A; Marquering HA; Reneman L; Caan MWA
    Am J Psychiatry; 2024 Mar; 181(3):223-233. PubMed ID: 38321916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design.
    Trivedi MH; McGrath PJ; Fava M; Parsey RV; Kurian BT; Phillips ML; Oquendo MA; Bruder G; Pizzagalli D; Toups M; Cooper C; Adams P; Weyandt S; Morris DW; Grannemann BD; Ogden RT; Buckner R; McInnis M; Kraemer HC; Petkova E; Carmody TJ; Weissman MM
    J Psychiatr Res; 2016 Jul; 78():11-23. PubMed ID: 27038550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical Connectivity Moderators of Antidepressant vs Placebo Treatment Response in Major Depressive Disorder: Secondary Analysis of a Randomized Clinical Trial.
    Rolle CE; Fonzo GA; Wu W; Toll R; Jha MK; Cooper C; Chin-Fatt C; Pizzagalli DA; Trombello JM; Deckersbach T; Fava M; Weissman MM; Trivedi MH; Etkin A
    JAMA Psychiatry; 2020 Apr; 77(4):397-408. PubMed ID: 31895437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial.
    Ang YS; Bruder GE; Keilp JG; Rutherford A; Alschuler DM; Pechtel P; Webb CA; Carmody T; Fava M; Cusin C; McGrath PJ; Weissman M; Parsey R; Oquendo MA; McInnis MG; Cooper CM; Deldin P; Trivedi MH; Pizzagalli DA
    Psychol Med; 2022 Oct; 52(13):2441-2449. PubMed ID: 33213541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study.
    Webb CA; Trivedi MH; Cohen ZD; Dillon DG; Fournier JC; Goer F; Fava M; McGrath PJ; Weissman M; Parsey R; Adams P; Trombello JM; Cooper C; Deldin P; Oquendo MA; McInnis MG; Huys Q; Bruder G; Kurian BT; Jha M; DeRubeis RJ; Pizzagalli DA
    Psychol Med; 2019 May; 49(7):1118-1127. PubMed ID: 29962359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression.
    Chin Fatt CR; Jha MK; Cooper CM; Fonzo G; South C; Grannemann B; Carmody T; Greer TL; Kurian B; Fava M; McGrath PJ; Adams P; McInnis M; Parsey RV; Weissman M; Phillips ML; Etkin A; Trivedi MH
    Am J Psychiatry; 2020 Feb; 177(2):143-154. PubMed ID: 31537090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
    JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized fMRI connectivity defines signatures of antidepressant and placebo responses in major depression.
    Zhao K; Xie H; Fonzo GA; Tong X; Carlisle N; Chidharom M; Etkin A; Zhang Y
    Mol Psychiatry; 2023 Jun; 28(6):2490-2499. PubMed ID: 36732585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis: A Randomized, Controlled Feasibility Trial.
    Friedli K; Guirguis A; Almond M; Day C; Chilcot J; Da Silva-Gane M; Davenport A; Fineberg NA; Spencer B; Wellsted D; Farrington K
    Clin J Am Soc Nephrol; 2017 Feb; 12(2):280-286. PubMed ID: 28126706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial.
    Pizzagalli DA; Webb CA; Dillon DG; Tenke CE; Kayser J; Goer F; Fava M; McGrath P; Weissman M; Parsey R; Adams P; Trombello J; Cooper C; Deldin P; Oquendo MA; McInnis MG; Carmody T; Bruder G; Trivedi MH
    JAMA Psychiatry; 2018 Jun; 75(6):547-554. PubMed ID: 29641834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
    Hedayati SS; Gregg LP; Carmody T; Jain N; Toups M; Rush AJ; Toto RD; Trivedi MH
    JAMA; 2017 Nov; 318(19):1876-1890. PubMed ID: 29101402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Pretreatment Reward Task Brain Activation Predict Individual Antidepressant Response: Key Results From the EMBARC Randomized Clinical Trial.
    Nguyen KP; Chin Fatt C; Treacher A; Mellema C; Cooper C; Jha MK; Kurian B; Fava M; McGrath PJ; Weissman M; Phillips ML; Trivedi MH; Montillo AA
    Biol Psychiatry; 2022 Mar; 91(6):550-560. PubMed ID: 34916068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals.
    Greenberg T; Fournier JC; Stiffler R; Chase HW; Almeida JR; Aslam H; Deckersbach T; Cooper C; Toups MS; Carmody T; Kurian B; Peltier S; Adams P; McInnis MG; Oquendo MA; Fava M; Parsey R; McGrath PJ; Weissman M; Trivedi M; Phillips ML
    Mol Psychiatry; 2020 Jul; 25(7):1526-1536. PubMed ID: 31462766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Concise Health Risk Tracking-Self Report: Psychometrics within a placebo-controlled antidepressant trial among depressed outpatients.
    Trombello JM; Killian MO; Grannemann BD; Rush AJ; Mayes TL; Parsey RV; McInnis M; Jha MK; Ali A; McGrath PJ; Adams P; Oquendo MA; Weissman MM; Carmody TJ; Trivedi MH
    J Psychopharmacol; 2019 Feb; 33(2):185-193. PubMed ID: 30652941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spotlight on sertraline in the management of major depressive disorder in elderly patients.
    Muijsers RB; Plosker GL; Noble S
    CNS Drugs; 2002; 16(11):789-94. PubMed ID: 12383038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
    ; Davidson JR; Gadde KM; Fairbank JA; Krishnan KRR; Califf RM; Binanay C; Parker CB; Pugh N; Hartwell TD; Vitiello B; Ritz L; Severe J; Cole JO; de Battista C; Doraiswamy PM; Feighner JP; Keck P; Kelsey J; Lin KM; Londborg PD; Nemeroff CB; Schatzberg AF; Sheehan DV; Srivastava RK; Taylor L; Trivedi MH; Weisler RH
    JAMA; 2002 Apr; 287(14):1807-14. PubMed ID: 11939866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.
    Kasper S; Hajak G; Wulff K; Hoogendijk WJ; Montejo AL; Smeraldi E; Rybakowski JK; Quera-Salva MA; Wirz-Justice AM; Picarel-Blanchot F; Baylé FJ
    J Clin Psychiatry; 2010 Feb; 71(2):109-20. PubMed ID: 20193645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic Resting-State Network Biomarkers of Antidepressant Treatment Response.
    Kaiser RH; Chase HW; Phillips ML; Deckersbach T; Parsey RV; Fava M; McGrath PJ; Weissman M; Oquendo MA; McInnis MG; Carmody T; Cooper CM; Trivedi MH; Pizzagalli DA
    Biol Psychiatry; 2022 Oct; 92(7):533-542. PubMed ID: 35680431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.